Avobenzone
Anthelios Sx, Capital Soleil (avobenzone) is a small molecule pharmaceutical. Avobenzone was first approved as Anthelios Sx on 2006-07-21. It is used to treat photosensitivity disorders in the USA.
Trade Name | Anthelios Sx, Capital Soleil |
---|---|
Common Name | Avobenzone |
Indication | photosensitivity disorders |
Drug Class |